Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$216,000.00

Specific and cell-permeable molecular probes of capital function

EF 2010-11

Résumé
The Calpain family of Ca2+-dependent proteases is involved in many physiological functions. Calpain dysfunction is implicated in many diseases. The greatest impact of Calpain proteases lies in their involvement in stroke, the third leading cause of death in Canada (source: Heart and Stroke Foundation). In addition to the damage done during hypoxic conditions of an ischemic stroke, the ischemic cascade contributes to a number of downstream effects even after the restoration of blood flow. The fact that over 88% of stroke survivors end up with some form of impairment or disability stresses the importance of battling this affliction and the need for new therapies. The low energy state of cells under anaerobic conditions shuts down the ATP-dependent ion exchange pumps, creating a large influx of Ca2+, thereby over-activating calpain. One of the targets of calpain is the Na+/Ca2+ exchanger which is cleaved during ischemia. The positive feedback loop rapidly pushes the cell down the death pathways of necrosis or apoptosis. Calpain inhibitors such as AK295 and SNJ1945 have been shown to reduce tissue damage upon experimental brain injury and stroke but have not been pursued further due to modest specificity. The grand challenge is to identify specific and potent calpain inhibitors that will not affect other cysteine proteases. Using the cyclic peptide methods developed recently in the Yudin lab, we will address the challenge of finding specific inhibitors for Calpains 1&2. Driven by a ground-breaking study published by Peter Davies (Nature 2008), we recently synthesized cyclic peptides for the unprimed area of the active site of the protease. This chemistry is based on a breakthrough disclosed by the Yudin lab in 2010 (JACS 2010, Chemical and Engineering News 2010, Faculty of 1000). Our cyclization technique allows facile incorporation of end-of-synthesis modifications to a key part in the structure, which we will use in order to fuse cyclic peptide inhibitors targeting both the primed and unprimed site of the calpain active site.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
222908
Name
Yudin Andrei
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Specific and cell-permeable molecular probes of capital function
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$216,000
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Cyclic Peptides
Abstract
The Calpain family of Ca2+-dependent proteases is involved in many physiological functions. Calpain dysfunction is implicated in many diseases. The greatest impact of Calpain proteases lies in their involvement in stroke, the third leading cause of death in Canada (source: Heart and Stroke Foundation). In addition to the damage done during hypoxic conditions of an ischemic stroke, the ischemic cascade contributes to a number of downstream effects even after the restoration of blood flow. The fact that over 88% of stroke survivors end up with some form of impairment or disability stresses the importance of battling this affliction and the need for new therapies. The low energy state of cells under anaerobic conditions shuts down the ATP-dependent ion exchange pumps, creating a large influx of Ca2+, thereby over-activating calpain. One of the targets of calpain is the Na+/Ca2+ exchanger which is cleaved during ischemia. The positive feedback loop rapidly pushes the cell down the death pathways of necrosis or apoptosis. Calpain inhibitors such as AK295 and SNJ1945 have been shown to reduce tissue damage upon experimental brain injury and stroke but have not been pursued further due to modest specificity. The grand challenge is to identify specific and potent calpain inhibitors that will not affect other cysteine proteases. Using the cyclic peptide methods developed recently in the Yudin lab, we will address the challenge of finding specific inhibitors for Calpains 1&2. Driven by a ground-breaking study published by Peter Davies (Nature 2008), we recently synthesized cyclic peptides for the unprimed area of the active site of the protease. This chemistry is based on a breakthrough disclosed by the Yudin lab in 2010 (JACS 2010, Chemical and Engineering News 2010, Faculty of 1000). Our cyclization technique allows facile incorporation of end-of-synthesis modifications to a key part in the structure, which we will use in order to fuse cyclic peptide inhibitors targeting both the primed and unprimed site of the calpain active site.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yudin, Andrei
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $216,000~ $0~